Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Serum METRNL Concentration in Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03194100
Recruitment Status : Completed
First Posted : June 21, 2017
Last Update Posted : June 21, 2017
Sponsor:
Information provided by (Responsible Party):
Bon Jeong Ku, Chungnam National University Hospital

Brief Summary:
The investigators measured serum METRNL levels in newly diagnosed patients with type 2 diabetes (T2DM) compared with normal glucose tolerance or prediabetes and explored the correlations between its serum levels and various metabolic parameters

Condition or disease
Diabetes Mellitus, Type 2

Layout table for study information
Study Type : Observational
Actual Enrollment : 125 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Comparison of Serum METRNL Concentration Between Type 2 Diabetes and Normal Glucose Tolerance
Actual Study Start Date : January 1, 2014
Actual Primary Completion Date : November 30, 2016
Actual Study Completion Date : November 30, 2016

Resource links provided by the National Library of Medicine


Group/Cohort
Diabetes Mellitus
Prediabetes
Normal glucose tolerance



Primary Outcome Measures :
  1. serum METRNL concentration [ Time Frame: on the 1 day of oral glucose tolerance test ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   19 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Oral glucose tolerance test (OGTT) was performed in all of the included participants. The participants were divided into three groups according to the American Diabetes Association criteria; normal glucose tolerance, prediabetes and diabetes mellitus.
Criteria

Inclusion Criteria:

  • Subjects who have not been diagnosed diabetes mellitus

Exclusion Criteria:

  • Person with diabetes who were treated with oral hypoglycemic agent or insulin
  • Individuals with type 1 diabetes, gestational diabetes, active hepatitis/liver cirrhosis, chronic renal failure on hemodialysis, congestive heart failure, or other known major disease

Layout table for additonal information
Responsible Party: Bon Jeong Ku, Professor, Chungnam National University Hospital
ClinicalTrials.gov Identifier: NCT03194100     History of Changes
Other Study ID Numbers: METRNL
First Posted: June 21, 2017    Key Record Dates
Last Update Posted: June 21, 2017
Last Verified: June 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases